Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > #RareDiseaseDay
View:
Post by prophetoffactz on Feb 28, 2023 12:24pm

#RareDiseaseDay

@BioasisUS
 
It's #RareDiseaseDay, a day to raise awareness about the challenges faced by people living with rare diseases. At Bioasis, we're committed to developing treatments for rare brain diseases that affect millions of people worldwide.
Comment by prophetoffactz on Feb 28, 2023 4:35pm
Cash until March and we are here... 19 days ago Midatech announced its financing with Ladenberg. BTI was recognized as far more valuable in the Biodexa transaction. If all that was next for BTI was a financing it should have been announced some time ago. Something more complicated? Are the lights even on? Today BTI Tweets that it is committed to developing treatments for rare brain diseases ...more  
biOasis Technologies Ord Shs